Lynette Arnell, Author at Pharmaphorum

The patient voice: A call to action

On December 13th 2016 the 21st Century Cures Act (Cures Act) was signed into law in the US.

The patient voice: A call to action

https://pharmaphorum.com/views-analysis-patients/patient-voice-call-action/

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

This article is the first in a series of three from Osprey Health Consulting that address the contemporary

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

https://pharmaphorum.com/views-analysis-sales-marketing/strategic-planning-increasingly-complex-uncertain-markets/

It’s time to get smart about blockchain in healthcare

Healthcare data is everywhere and more is coming – data from wearables, data from Internet of Things devices,

It’s time to get smart about blockchain in healthcare

https://pharmaphorum.com/digital/its-time-to-get-smart-about-blockchain-in-healthcare/

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time? Their co-dependent

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

https://pharmaphorum.com/r-d/views-analysis-r-d/art-storytelling-clinical-data-communication/

Writer

This is an exciting opportunity to join a high growth digital media company, which has both online publications

Writer

https://pharmaphorum.com/jobs/writer-publishing-division/

Cambridge Rare Disease Network (CRDN) Company Forum Meeting Friday 20th July 2018

The next Cambridge Rare Disease Network (CRDN) Company Forum meeting will be held on Friday, 20th July 2018

Cambridge Rare Disease Network (CRDN) Company Forum Meeting Friday 20th July 2018

https://pharmaphorum.com/partner-content/cambridge-rare-disease-network-crdn-company-forum-meeting-friday-20th-july-2018/

From evidence-based medicine to digital-based health

The concept of evidence-based medicine (EBM), coined by Gordon Guyatt in 1992 to refer to the use of

From evidence-based medicine to digital-based health

https://pharmaphorum.com/digital/evidence-based-medicine-digital-based/

To unlock innovation, pharma needs to be honest about failure

Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation –

To unlock innovation, pharma needs to be honest about failure

https://pharmaphorum.com/views-and-analysis/unlock-innovation-pharma-honest-failure/

20/06/2017

Disruption and maturity: the future directions for biologics

Is the UK’s NHS saving enough from the new wave of biosimilars?

Disruption and maturity: the future directions for biologics

https://pharmaphorum.com/debates-insight-market-access/disruption-maturity-future-directions-biologics/

Trending

About Lynette Arnell

Posts by Lynette Arnell:

The patient voice: A call to action

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

It’s time to get smart about blockchain in healthcare

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

Writer

Cambridge Rare Disease Network (CRDN) Company Forum Meeting Friday 20th July 2018

From evidence-based medicine to digital-based health

To unlock innovation, pharma needs to be honest about failure

Disruption and maturity: the future directions for biologics

Search

Advanced Search

Trending

About Lynette Arnell

Posts by Lynette Arnell: